Literature DB >> 7714491

Clinical recurrence of hepatitis A following liver transplantation for acute liver failure.

E Gane1, R Sallie, M Saleh, B Portmann, R Williams.   

Abstract

This paper documents clinically significant recurrence of hepatitis A virus (HAV) infection in a 63-year-old man transplanted for HAV-related acute liver failure. HAV RNA was documented in the explant and, following early clearance from the blood and graft, was again detected in post-operative biopsies at the time of an acute hepatic illness. Although the clinical and biochemical abnormalities resolved completely, the patient had a second episode of graft dysfunction 6 months later and investigations revealed hepatitis C virus (HCV)-related chronic active hepatitis consistent with acquired HCV infection at the time of transplantation. The possible interaction with hepatitis A may have delayed the appearance of hepatitis C. Administration of HAV immunoglobulin at the time of transplantation should be considered in all cases of HAV-related fulminant hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714491     DOI: 10.1002/jmv.1890450107

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

Review 1.  Hepatitis A: old and new.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

2.  A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients.

Authors:  Thaninee Prasoppokakorn; Jakapat Vanichanan; Roongruedee Chaiteerakij; Kamonwan Jutivorakool; Suwasin Udomkarnjananun; Krit Pongpirul; Wipusit Taesombat; Salin Wattanatorn; Yingyos Avihingsanon; Kriang Tungsanga; Somchai Eiam-Ong; Kearkiat Praditpornsilpa; Natavudh Townamchai
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.